Friday, May 1, 2026

Anti-North Korea Radio Broadcasts Plummet 80% as US, South Korea Halt Transmissions

Radio broadcasts targeting North Korea have dropped 80%, with significant cuts from the U.S. and South Korea amid easing tensions.

Analysis: China’s Reluctance on Denuclearization Poses Challenge for US and Its Allies

Foreign Minister Cho Hyun urges China to aid in North Korea negotiations, emphasizing cooperation for peace and economic collaboration.

SK Hynix’s Record-Breaking Sales: How North America Fueled a 75% Revenue Surge

SK Hynix's U.S. memory sales doubled last year, with record earnings and significant investments for future growth.

Tag: solid tumors

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.